Back to search

Article

Oncogenic CD44 is required for pancreatic cancer cell tumorigenesis and CD44 gene knockout is a new strategy for targeted pancreatic cancer therapy

2024-01-08

Abstract excerpt

<title>Abstract</title> <p>CD44 is a cancer stem cell marker and is aberrantly overexpressed in cancer stem/progenitor cells of malignant tumors. Overexpression of CD44 promotes carcinogenesis and is closely associated with poor prognosis in cancer patients, including pancreatic cancer. However, CD44-targeted drug against pancreatic cancer is unavailable in the clinical setting, and the effect of <italic>CD44</it...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db6fed8b-3f52-5827-bcb7-7d7057429463
DOI
10.21203/rs.3.rs-3677039/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oncogenic CD44 is required for pancreatic cancer cell tumorigenesis and CD44 gene knockout is a new strategy for targeted pancreatic cancer therapyDOI 10.21203/rs.3.rs-3677039/v1
Select a neighboring publication to make it the new centre.